Search results for "Kidney diseases"

showing 10 items of 117 documents

Chronic kidney disease and inflammation: Role of +896A/G pro-inflammatory polymorphism of TLR4 gene and Δ32 deletion of CCR5 gene

2009

bstract Chronic inflammation seems implicated in the pathophysiology of chronic kidney diseases (CKD) and the development of its complications, such as cardiovascular diseases (CVD). Genes encoding inflammatory molecules are, hence, good candidates for CVD risk in haemodialysis patients (HD). We therefore evaluated whether +896A/G TLR4 polymorphism and CCR5A32 deletion are risk factors for CKD and CVD. We examined the two gene variants in 72 HD patients and in 125 controls from Sicily. No significant differences in the genotype distribution and allele frequencies of the two gene variants were observed between patients and controls. The same results were obtained by analysing the combined ef…

Inflammationbusiness.industryImmunologylcsh:Rlcsh:MedicineInflammationmedicine.diseaseCVDPathophysiologyChronic Kidney DiseasesCCR5; CKD; CVD; Inflammation; TLR4ImmunologymedicineTLR4CKDImmunology and AllergySettore MED/05 - Patologia ClinicaTLR4medicine.symptombusinessGeneCCR5Kidney disease
researchProduct

Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19)

2020

Abstract Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory disease, which can evolve into multi-organ failure (MOF), leading to death. Several biochemical alterations have been described in COVID-19 patients. To date, many biomarkers reflecting the main pathophysiological characteristics of the disease have been identified and associated with the risk of developing severe disease. Lymphopenia represents the hallmark of the disease, and it can be detected since the early stage of infection. Increased levels of several inflammatory biomarkers, including c-reactive protein, have been found in COVID-19 patients and associ…

Kidney DiseaseClinical BiochemistryMyocardial InfarctionMedicine (miscellaneous)Disease030204 cardiovascular system & hematologySeverity of Illness Index0302 clinical medicineBiomarkers Coronavirus Infection030212 general & internal medicinebiochemical alterationAged 80 and overHealth PolicyLiver DiseasesMusclesLiver DiseaseRespiratory diseaseBlood Coagulation DisordersWater-Electrolyte BalancePathophysiologyC-Reactive ProteinDisease ProgressionCytokinesbiomarkerMuscleKidney DiseasesLiver dysfunctionCoronavirus InfectionsHumanCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia Viralmacromolecular substances03 medical and health sciencesBetacoronavirusLymphopeniamedicineHumansCytokinePandemicsAgedInflammationBlood Coagulation DisorderBetacoronavirubusiness.industrySARS-CoV-2Biochemistry (medical)Public Health Environmental and Occupational HealthCOVID-19Biochemical biomarkersmedicine.diseaseImmunologyCytokine stormbusinesslaboratoryBiomarkers
researchProduct

Left ventricular mass in hypertensive patients

2010

Left ventricular maChronic kidney diseasesArterial Hypertension
researchProduct

β-Thalassemia heterozygote state detrimentally affects health expectation.

2018

Background: Thalassemia minor (Tm) individuals, are generally considered healthy. However, the prognosis of Tm individuals has not been extensively studied. The aim of this study was to evaluate the prognosis of Tm versus controls without β-thalassemia carrier state. Methods: A total of 26,006 individuals seeking thalassemia screening at the AOOR Villa Sofia-V. Cervello, Palermo (Italy) were retrospectively studied. Logistic penalised regression model was used to estimate risk of potential complications and survival techniques were used to study mortality. Results: We identified a total of 4943 Tm and 21,063 controls. Tm was associated with significantly higher risks of hospitalisation for …

Liver Cirrhosismedicine.medical_specialtyHeterozygoteCirrhosisThalassemia MinorThalassemia030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineβ-Thalassemia carrier stateLife ExpectancyCholelithiasisInternal medicineInternal MedicineMedicineHumansMortalityThalassemia minorHealth expectationbusiness.industryMood DisordersCarrier statebeta-ThalassemiaHeterozygote advantagemedicine.diseaseHospitalizationThalassemia screeningLogistic ModelsMood disordersItalyKidney DiseasesKidney disorderbusiness030215 immunologyEuropean journal of internal medicine
researchProduct

When kidneys and lungs suffer together

2018

A significant interaction between kidneys and lungs has been shown in physiological and pathological conditions. The two organs can both be targets of the same systemic disease (eg., some vasculitides). Moreover, loss of normal function of either of them can induce direct and indirect dysregulation of the other one. Subjects suffering from COPD may have systemic inflammation, hypoxemia, endothelial dysfunction, increased sympathetic activation and increased aortic stiffness. As well as the exposure to nicotine, all the foresaid factors can induce a microvascular damage, albuminuria, and a worsening of renal function. Renal failure in COPD can be unrecognized since elderly and frail patients…

Lung DiseasesNephrologymedicine.medical_specialty030232 urology & nephrologyRenal functionSettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologyLung injuryPulmonary Disease Chronic Obstructive03 medical and health sciencesMechanical ventilation0302 clinical medicineRenal DialysisInternal medicineAcute lung injuryCOPD; Pulmonary-renal syndrome; Mechanical ventilation; Acute lung injury; Acute kidney injuryHumansCOPDMedicinebusiness.industryAcute kidney injurymedicine.diseaseAcute kidney injuryrespiratory tract diseasesPneumoniaNephrologyPulmonary-renal syndromeAlbuminuriaCardiologyKidney Failure ChronicKidney Diseasesmedicine.symptomRenal compensationbusinessKidney diseaseJournal of Nephrology
researchProduct

Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants

2020

AbstractAs a result of the successful completion of their respective phase III studies compared with vitamin K antagonists (VKAs), four direct oral anticoagulants (DOACs) have been approved for the treatment and secondary prevention of venous thromboembolism (VTE). These DOACs—apixaban, dabigatran, edoxaban, and rivaroxaban—have subsequently seen a steady uptake among clinicians since their approval. Despite the suitability of DOACs for a broad range of patients, they are not appropriate in certain situations, whereas in others they require additional considerations such as dose reductions. Subanalyses of phase III trials and studies on specific VTE patient populations have been conducted t…

Male0301 basic medicineComorbidity030204 cardiovascular system & hematologychemistry.chemical_compound0302 clinical medicinePregnancyEdoxabanNeoplasmsSecondary PreventionChildspecial populationsAge FactorsVenous ThromboembolismHematologyMiddle AgedTreatment OutcomePractice Guidelines as TopicFemaleKidney Diseasesmedicine.drugAdultmedicine.medical_specialtyMEDLINEHemorrhagecomorbiditiesdirect oral anticoagulantsDabigatran03 medical and health sciencesmedicineHumansLactationDosingIntensive care medicineAgedDose-Response Relationship Drugbusiness.industryPatient SelectionPregnancy Complications HematologicContraindications DrugAnticoagulantsmedicine.diseaseComorbidityReview articleClinical trial030104 developmental biologyClinical Trials Phase III as TopicchemistrybusinessVenous thromboembolismFactor Xa InhibitorsThrombosis and Haemostasis
researchProduct

Fifteen years of research on oral-facial-digital syndromes: from 1 to 16 causal genes

2017

Oral–facial–digital syndromes (OFDS) gather rare genetic disorders characterised by facial, oral and digital abnormalities associated with a wide range of additional features (polycystic kidney disease, cerebral malformations and several others) to delineate a growing list of OFDS subtypes. The most frequent, OFD type I, is caused by a heterozygous mutation in theOFD1gene encoding a centrosomal protein. The wide clinical heterogeneity of OFDS suggests the involvement of other ciliary genes. For 15 years, we have aimed to identify the molecular bases of OFDS. This effort has been greatly helped by the recent development of whole-exome sequencing (WES). Here, we present all our published and …

Male0301 basic medicineHeterozygoteciliopathieOral facial digital[SDV]Life Sciences [q-bio][ SDV.BBM.BM ] Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biologyBiologyCiliopathiesCentriole elongation03 medical and health sciencesIntraflagellar transportGenotypeGeneticsPolycystic kidney diseasemedicineHumansAbnormalities Multiple[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyFunctional studies[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyGene*oral-facial-digital syndromesGenetics (clinical)ComputingMilieux_MISCELLANEOUSEncephaloceleGeneticsPolycystic Kidney Diseases[ SDV ] Life Sciences [q-bio]*ciliopathiesProteinsMetabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6][SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biologyOrofaciodigital Syndromesmedicine.disease030104 developmental biologyFaceMutationciliopathiesoral-facial-digital syndromesFemaleRetinitis PigmentosaRare cancers Radboud Institute for Health Sciences [Radboudumc 9]Ciliary Motility Disorders
researchProduct

CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney Disease

2021

The CD73 pathway is an important anti-inflammatory mechanism in various disease settings. Observations in mouse models suggested that CD73 might have a protective role in kidney damage

Male0301 basic medicinePathologyCCR2podocyte030232 urology & nephrologyGene ExpressionKidneyPodocyte0302 clinical medicineFocal segmental glomerulosclerosisMedicineMinimal change diseaseBiology (General)5'-NucleotidaseSpectroscopyAged 80 and overKidneymedicine.diagnostic_testPodocytesGlomerulonephritisGeneral MedicineMiddle AgedComputer Science ApplicationsChemistryProteinuriaminimal change diseasemedicine.anatomical_structureImmunohistochemistryFemaleKidney DiseasesAdultmedicine.medical_specialtyQH301-705.5Receptors CCR2GPI-Linked ProteinsImmunofluorescenceArticleCatalysisInorganic Chemistry03 medical and health sciencesHumansPhysical and Theoretical ChemistryQD1-999Molecular BiologyAgedbusiness.industryOrganic Chemistrymedicine.disease030104 developmental biologyGene Expression RegulationCD73CCR2businessBiomarkersInternational Journal of Molecular Sciences
researchProduct

Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancer.

1992

Twenty-two patients with advanced head and neck carcinoma were treated with 5FU 400 mg-2 m-1 week and folinic acid 500 mg m-2 week-1 plus CDDP in escalating doses from 20 to 40 mg m-2 week-1 without forced diuresis. Reduced gluthatione at the dose of 1.5 g m-2 was employed to protect patients from CDDP-related nephrotoxicity. The aims of the study were: a) to evaluate the therapeutic efficacy of this schedule, and b) to evaluate reduced gluthatione as uroprotector. Out of 20 evaluable patients 14 (70 %) had a major objective response. A CR with a mean duration of 9.0+ months was achieved in 15 % of the patients, a PR of 5.8+ months in 55 % of the patients, while 3 patients had stable diseas…

MaleCancer Researchmedicine.medical_specialtyUrologyLeucovorinHead/neck cancerDrug Administration ScheduleNephrotoxicityCatalysiFolinic acidInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansIn patientPharmacology (medical)NephrotoxicityAgedCisplatinHematologyDose-Response Relationship Drugbusiness.industryHead and neck cancerChemistry (all)Folinic acidMiddle Agedmedicine.diseaseGlutathioneOncologyFluorouracilHead and Neck NeoplasmsAnesthesiaPharmacology Toxicology and Pharmaceutics (all)ToxicityFemaleKidney DiseasesFluorouracilGluthationeCisplatinbusinessmedicine.drugMedical oncology and tumor pharmacotherapy
researchProduct

Is there association between chronic kidney disease and dental caries? A case-controlled study

2018

Background The purpose of this study was to assess the association between chronic kidney diseases (CKD) and dental caries. Material and Methods 107 patients with CKD and 107 with no systemic alteration were randomly included. DMFT (decayed, missing, and filled teeth), plaque index, colony-forming units (CFU) of Streptococcus mutans and salivary composition (IgA total, IgA anti- Streptococcus mutans, calcium and urea) were evaluated. McNemar and Wilcoxon tests were used to compare test and control groups. Spearman test was used to correlate time of hemodialysis and variables studied. Associations between variables were evaluated by logistic regression analysis. Results The number of filled …

MaleCross-sectional studyColony Count MicrobialOral Healthurologic and male genital diseasesStreptococcus mutans0302 clinical medicineChronic Kidney DiseasesMedicineUreaYoung adultAged 80 and overbiologyDental Plaque IndexMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in DentistryAntibodies Bacterialfemale genital diseases and pregnancy complicationsDental Plaque IndexUNESCO::CIENCIAS MÉDICASRegression AnalysisFemaleAdultmedicine.medical_specialtyDental Caries03 medical and health sciencesYoung Adultstomatognathic systemRenal DialysisInternal medicineHumansRenal Insufficiency ChronicSalivaGeneral DentistryAgedurogenital systembusiness.industryResearchCase-control study030206 dentistrymedicine.diseasebiology.organism_classificationStreptococcus mutansImmunoglobulin Astomatognathic diseasesCross-Sectional StudiesLogistic ModelsOtorhinolaryngologySocioeconomic FactorsCase-Control StudiesColony countSurgeryCalciumbusinessKidney disease
researchProduct